Purchase Order 75N91025P00052
Award Date
12/29/24
Potential Completion Date
12/28/25
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,734.40 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has received numerous federal contract awards, including through General Services Administration (GSA) Schedule contracts,...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The $8,028.69 contract provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. Roche Diagnostics has been awarded multiple federal contracts and subcontracts to supply medical and surgical equipment or supplies to agencies including the Department of...
This is a Firm Fixed Price delivery order contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $26,365.32 contract is for the provision of unspecified products and services, with a period of performance ending on April 14, 2016. This award is associated with a larger Indefinite Delivery Contract or Blanket Purchase Agreement held...
This $9,173 firm fixed price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation on August 22, 2016. The award does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, has provided critical care analyzers, reagents, test kits,...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for a maintenance agreement. The contract has a ceiling value of $15,649.28 and a ultimate completion date of December 28, 2025. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a $23,500 fixed-price purchase order awarded to Roche Diagnostics Corporation by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services. The contract is not set aside. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, is providing critical care analyzers, reagents, test kits, and associated products and services to support the National Institutes of Health's medical...
Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the National Cancer Institute, a component of the Department of Health and Human Services, with a potential value of $15,649.32. The agreement is for services to be performed at the agency's location in Rockville, Maryland, with a completion date of March 24, 2025. No set-aside designation was applied. This purchase order is likely placed against an existing Indefinite Delivery Contract or Blanket Purchase Agreement...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $618,623.01, is for the delivery of critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. Roche Diagnostics has a long history of supporting federal...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $34,568.82 firm fixed-price contract has a completion date of December 9, 2019 and does not include a set-aside designation. Roche Diagnostics has received numerous federal contract awards, including through General Services...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation for $15,445.60. The contract, which does not have a set-aside designation, is for the delivery of DABMAP KIT medical supplies. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products and services, has a history of...